Effect of Oral Water in Healthy Volunteers on Cardiac Output, Regional Flow and Microcirculation in Healthy Volunteers
WATERNAL
1 other identifier
interventional
59
1 country
1
Brief Summary
Human digestive system physiologically ensures the absorption of oral water and hydration of the human body. Water is quickly absorbed by the digestive tract with a peak between 15 and 20 minutes. It has demonstrated that oral water remains the best hydration solution that have an effect on plasma volume expansion and cardiovascular system during exercise. While the cardiovascular effect of fluid expansion by saline serum is well known (venous return, preload and cardiac output), effect of oral water varies in the literature depending on the physiological state of the patient and the clinical state. Thus, the investigators aim to investigate oral water effects on fluid responsiveness, regional blood flow and microcirculatory changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2021
CompletedStudy Start
First participant enrolled
November 30, 2021
CompletedFirst Posted
Study publicly available on registry
December 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2023
CompletedMay 28, 2025
May 1, 2025
1.7 years
November 30, 2021
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of fluid responders 30 minutes after fluid expansion
30 minutes after fluid expansion
Study Arms (2)
oral water
EXPERIMENTALExperimental group: oral administration of 500 ml of water.
intravenous
ACTIVE COMPARATORActive comparator: Administration of 500 mL of saline (NaCl 0.9%) administered by the venous route
Interventions
Administration of 500 mL of saline (NaCl 0.9%) administered by the venous route
Eligibility Criteria
You may qualify if:
- Healthy volunteer subject between 18 and 30 years old
- patient with a regular sinus rhythm
- Echogenic subject.
- Fasting of solid and liquid since 8 h
- Subject in regular sinus rhythm.
- Written consent signed.
You may not qualify if:
- Any known cardiac, renal or endocrine pathology.
- Arrhythmia rhythm disorder by atrial fibrillation
- Pregnant or nursing woman.
- Pathology versus indicating Nacl administration.
- Person under tutors or curators or deprived of liberty.
- Person not affiliated to a social security scheme.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens-Picardie
Amiens, 80054, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2021
First Posted
December 10, 2021
Study Start
November 30, 2021
Primary Completion
August 28, 2023
Study Completion
August 28, 2023
Last Updated
May 28, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share